IMPORTANCE Current treatments for alopecia with autograft hair transplantation face limitations that may preclude complete hair restoration and leave patients with donor site scars. Scaffold assisted artificial hair implantation as demonstrated in a rat model may provide an adjunct for hair restoration without donor site morbidity.
A lopecia occurs when the normal repopulation of hair is disrupted. The most common form is androgenic alopecia, with frontotemporal and vertex hair loss, sparing the occipital scalp. Androgenic alopecia affects more than 50% of men by age 50 years. 1 The severity of androgenic alopecia has been stratified by the Norwood Classification. 2 In addition to patterned baldness, hair loss may result from alopecia areata, an autoimmune inflammatory condition, telogen effluvium, trauma, or postsurgical scarring. Treatment of alopecia has included medical, as well as surgical, therapies. Minoxidil and finasteride are approved for medical treatments of androgenic alopecia. [3] [4] [5] [6] Currently, autograft hair transplantation is the gold-standard surgical treatment for alopecia. [7] [8] [9] [10] [11] Hair follicles are removed from the nonbalding occipital scalp in a linear strip by follicular unit transplantation or through individual punches by follicular unit extraction and then surgically transplanted to areas of alopecia. [7] [8] [9] [10] [11] However, autograft hair transplantation, while able to produce longlasting and safe results, is not without morbidity and limitation. Donor site morbidity in follicular unit transplantation results in a conspicuous occipital linear scar, especially in patients who wear their hair shorter than 1 to 2 cm. [8] [9] [10] [11] Follicular unit extraction, adopted to prevent need for a strip of donor hair, is limited by lower yield in viable follicular units. 10, 11 Additionally, owing to the low yield, multiple rounds of hair harvesting may be required, which may result in donor scalp cobblestoning, hair thinning, and limit further hair transplant procedures. 8, 10, 11 Patients with advanced hair loss (ie, Norwood VI, VII, or alopecia totalis/universalis) may have such limited donor site hair that the improvement of hair coverage by autograft hair transplantation may not be possible or may not achieve complete hair coverage. 8 In these patients, a series of artificial hair implants may be able to create hair coverage where donor site hair is unavailable. In addition, in patients with alopecia from traumatic scarring, artificial hair implantation may provide coverage in the scarred tissue without creating further donor site scarring. Prior attempts at artificial hair implantation were not approved by the US Food and Drug Administration (FDA) owing to complications including folliculitis, extrusion, and skin inflammation. 12 A clinical trial 13 in India of Biofiber, an Italian artificial hair, has shown infection rates of 30% and extrusion rates of 20% per year. There are numerous examples of safe, FDA-approved implants, including rhinoplasty, malar, and dental implants. Porous high-density polyethylene (PHDPE) and expanded polytetrafluoroethylene (ePTFE) have been shown to be biocompatible, nonbiodegradable, able to retain shape, and FDA approved in facial implants. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] The goal of this study was to explore the role of PHDPE and ePTFE scaffold-assisted artificial hair implantation in a rat model.
Methods

Scaffold Design
The scaffold consisted of a body and lateral flaps in a "t" shape measuring 10 × 10 × 3 mm (L × W × H) ( Figure 1) . In head and neck surgery, t-shaped implants have been used to promote retention and prevent extrusion of the implant. 24 The scaffold was carved in a sterile fashion with a No. 15 blade from sterile PHDPE (Stryker) or ePTFE blocks (Surgiform).
Scaffold Hair Insertion
When artificial hair was required, 5-cm industrial grade red kanekalon hair was sterilized in a 5-minute betadine wash. Four strands of hair were knotted at one end to simulate a follicular unit. At the other end, the strands of hair were fixed to a sterile Keith needle. The needle was passed from the base of the scaffold through the top, pulling the hair through the scaffold until the knotted end was mechanically fixed to the base of the scaffold body. Each hair bearing scaffold had 2 follicular units of hair inserted at the one-third and two-third points of the scaffold body, ensuring at least a 1-mm border of scaffold margin around each follicular unit of hair. Thus, each hairbearing scaffold implanted 2 follicular units ( Figure 1 ).
Structural Integrity Evaluation
The tensile strength of the hair fixed to the scaffolds was evaluated to ensure the ability to withstand forces from the activities of daily living (approximately 0.3 N). 25 The hair was clamped and the scaffold body was suspended from a spring scale. A sustained load of more than 0.3 N was confirmed for each scaffold.
Surgical Implantation of Scaffolds in a Rat Model
This experimental protocol was approved by the University of California, Los Angeles, Institutional Animal Care and Use Committee. Three-month old male Sprague Dawley rats, weighing 200 to 250 g, were selected as a wound-healing animal model. 26 Thirty-four rats were randomly selected into 2 groups:
24 rats for direct implantation and 10 rats for delayed implantation. The direct-implantation group was randomly divided into 3 subgroups of 8 rats that were observed for 2, 12, and 24 week, because, in patients with alloplastic implants, infectious complications usually occurred within 3 months. 27 All surgical procedures were performed with aseptic technique. The rats were placed in the prone position and anesthetized with inhaled isoflurane 2% to 4% to effect. Buprenorphine 0.05 mg/kg was given subcutaneously for pain management. Nonsteroidal anti-inflammatory analgesia and antibiotics were not used so as not to confound the incidence of infection. The animal was prepared aseptically by shaving the dorsum from the caudal aspect of the scapula to the cephalic aspect of the pelvis. The skin was then disinfected with 3 alternating betadine and alcohol scrubs and bland ophthalmic ointment was placed in the eyes during anesthesia.
Four-quadrant scaffold implantation was planned with incisions placed 3 cm apart to minimize the potential confounding effect of each implant on the rest. One-centimeter incisions were made with a No. 15 blade through the panniculus carnosus muscle, and blunt dissection deep to the panniculus carnosus muscle created a surgical implantation pocket. [28] [29] [30] Each rat was implanted with a set of scaffolds including: (1) PHDPE with hair; (2) PHDPE without hair; (3) ePTFE with hair; and (4) ePTFE without hair, allowing scaffolds without hair to serve as controls to the scaffolds with hair. The location of each scaffold implantation was randomized by quadrant to control for preferential animal grooming habits. Each incision was then closed with 2 simple interrupted 5-0 polypropylene stiches through the panniculus carnosus muscle and skin. The rats in the directimplantation group were observed to their selected time points of 2, 12, and 24 weeks. The rats in the delayed-implantation group were observed for 4 weeks, at which point all well-healed scaffolds without hair were then percutaneously implanted with 2 follicular units of hair. These rats were then observed for another 4 weeks.
During the clinical observation period, scaffolds were observed for signs of infection, extrusion, and persistence of follicular units. Following sacrifice, sagittal sections of scaffold and surrounding skin were fixed in formalin and stained with hematoxylin-eosin and evaluated for degree of fibrovascular invasion, as well as acute and chronic inflammation.
In Vivo Evaluation of Implants
The healing of implants were evaluated postsurgically at 24 hours, 48 hours, 1 week, 2 weeks, 1 month, 3 months, and 6 months, when applicable. The implant sites were evaluated for signs of infection and extrusion, as well as retention of implanted follicular units. Implants that were completely extruded and absent within 48 hours of implantation were noted as extruded samples, and excluded from follicular unit survival, scaffold survival, and histological analysis. If implants showed signs of infection and partial extrusion, the implant was explanted, while the other implants remained in place. Partially extruded implants at final evaluation were included in follicular unit survival, scaffold survival, and histological analysis. Completely extruded implants were lost samples and were excluded from follicular unit, survival, scaffold survival, and histological analysis.
Data Collection and Analysis
At the designated time points, the 8 rats in each group were euthanized. The presence of infection or extrusion was noted and the number of retained follicular hair units was recorded. The implants were then excised from the rat dorsum with a 5-mm margin of tissue. Specimens were fixed in 10% formalin for 48 hours, paraffin sectioned to 7 micron thickness at the level of the artificial hair shaft, and stained with hematoxylin-eosin for histological analysis. 31 Analysis included the degree of acute and chronic inflammation, percentage of fibrovascular integration, and the degree of inflammation at the hair insertion site of the scaffold. Periscaffold acute and chronic inflammation, as well as hair shaft inflammation, were measure in a semiquantitative scale: 0, no inflammation; 1, mild inflammation, small number of disseminated neutrophils or lymphocytes; 2, moderate inflammation, moderate number of neutrophils or lymphocytes clustered in groups; or 3, severe inflammation, large number of cells with dense cellular infiltrate. 31 Fibrovascular integration was measured as a percentage of the scaffold integrated by surrounding fibrovascular tissue. 32 
Statistical Analysis
Power calculations with G*Power (Heinrich-Heine-Universität Düsseldorf) confirmed the need for a minimum of 7 rats per group to establish if PHDPE scaffold exhibits less infection and better biocompatibility than the ePTFE scaffold and may serve as a hair-containing artificial hair implant in a rat model. 33 This was based upon the hypothesis that PHDPE, with its larger pore size and potential for fibrovascular integration will have a large (effect size of f = 0.8) impact on decreasing infection and extrusion; α was set to .05, and the power at 0.8. Statistical analyses were performed using SPSS 24 software (IBM Corp). Analysis of acute inflammation, chronic inflammation, fibrovascular integration, and hair shaft inflammation were evaluated between scaffolds with and without hair, between different scaffold materials, and across sacrifice time points by independent-sample t test analysis. Statistical significance was determined at the P < .05 threshold.
Scaffold survival and follicular unit survival was evaluated by the Kaplan-Meier method with the pooled data of the 2 week, 12 week, and 24 week groups. Differences in survival were formally evaluated using the log-rank test. Similarly, scaffold and follicular unit survival analysis of the delayed group were evaluated by Kaplan-Meier log-rank test.
Results
Overall, 94% (86 of 91) of the implanted scaffolds were well healed at the time of evaluation (2 week, 100% [32 of 32]; 12 week, 96% [26 of 27] ; 24 week, 88% [28 of 32]). Of the 2-week group, all scaffolds were well healed. Of the 12-week group, 5 scaffolds (1 PHDPE with hair, 2 PHDPE without hair, 2 ePTFE without hair) were dislodged by animal grooming within a day after implantation and were excluded from the study. Of the remaining 27 scaffolds, 26 were well healed at 12 weeks, and only 1 scaffold (ePTFE with hair) was partially extruded upon final evaluation. Of the 24-week group, 28 of 32 scaffolds were well healed at the time of evaluation (Figure 2) . Three scaffolds had extruded (2 PHDPE with hair, and 1 PHDPE without hair) and 1 PHDPE with hair had partially extruded upon final evaluation. When analyzing scaffold survival based on material, there was no difference in scaffold survival between ePTFE and PHDPE scaffolds (Kaplan-Meier log-rank, P = .30). Similarly, there was no scaffold survival difference between scaffolds with hair and scaffolds without hair (Kaplan-Meier logrank, P = .72).
Of the delayed group, 1 scaffold (PHDPE with hair) was dislodged by animal grooming within 48 hours of implantation and excluded from the study. In addition, 2 scaffolds (1 ePTFE and 1 PHDPE) had superficial abrasion noted at 4 weeks and did not have hair implanted and were excluded from the remainder of the study. All 19 of the initially implanted scaffolds were well healed, and all 18 of the delayed implanted scaffolds were well healed at the 8 week time of evaluation. Kaplan-Meier log-rank analysis showed no significant difference in scaffold survival between initially implanted scaffolds and scaffolds implanted with hair 4 weeks after implantation (P = .34). There was also no significant difference in scaffold survival (P = .32) when analyzing between scaffold materials (ePTFE vs PHDPE) in the delayed-implantation group by Kaplan-Meir log-rank analysis.
Overall, 86% of artificial hair follicular units were intact at time of evaluation (2 week, 94% [ ). There was no statistically significant difference of follicular unit survival between ePTFE and PHDPE scaffolds (Kaplan-Meier log-rank, P = .72) based on scaffold material. Within the delayed-implantation group, 95% (36 of 38) of the initially implanted follicular units remained intact; 89% (32 of 36) of the delay-implanted follicular units remained intact. Kaplan-Meier log-rank analysis showed no significant difference in follicular unit survival (P = .24) between initially implanted scaffolds and delayed-implantation scaffolds. There was also no significant difference in follicular unit survival (P = .68) between ePTFE and PHDPE scaffolds in the delayed-implantation group.
All animals survived the procedures. No major complications were noted postoperatively. All areas with previously extruded implants were well healed and did not require sacrifice of rats or explantation of neighboring scaffolds.
Upon histological analysis, there was no statistical difference between materials or hair status in the scaffolds at the 2-week time point (Table 1) . At the 12-week time point, there were statistical differences in chronic inflammation and degree of fibrovascular integration between ePTFE and PHDPE scaffolds. At the 24-week time point, there was statistically significant greater acute and chronic inflammation of scaffolds with hair than scaffolds without hair (Table 1 ). There was no significant difference between the level of inflammation of the hair shafts of ePTFE and PHDPE scaffolds with hair at all time points (Table 1; Figure 3) . Overall, scaffolds with hair were noted to have greater chronic inflammation (95% CI, −0.81 to −0.10; P = .01), and PHDPE was noted to have significantly greater fibrovascular integration (95% CI, −11.42 to −1.96; P = .01) compared with ePTFE (Table 1) .
Histological analysis of the delayed group noted significant differences in fibrovascular integration, chronic inflammation, and hair shaft inflammation between ePTFE and PHDPE ( Table 2) . However, notably, there were no significant differences in acute inflammation, chronic inflammation, fibrovascular integration, or hair shaft inflammation between scaffolds with hair and scaffolds with delay-implanted hair.
Discusssion
In this study, artificial hair-bearing scaffolds were engineered from ePTFE and PHDPE. At 24 weeks, 75% of artificial hair follicular units were intact with no significant difference between follicular unit survival between ePTFE and PHDPE scaffolds. This rate of retention is less than the rates of human hair turnover of 0.1% per day 5 and previous human studies of individual artificial hair implants of 15% to 20% per year. 10 However, lower rate of follicular unit retention may be explained by the social grooming of rats, which may place repetitive tensile and sheering forces on the follicular units. Future implants may be engineered to withstand these greater strains from social grooming. At 24 weeks, 88% of the implanted scaffolds were intact and well healed at the time of evaluation. This is comparable Comparison is statistically significant.
Research Original Investigation
Scaffold-Assisted Artificial Hair Implantation in a Rat Model to prior studies in rat models with PHDPE and ePTFE. 34, 35 Wellhealed scaffolds may provide a milieu for further implantation of artificial hair. Delayed implantation of hairs after 4 weeks had no significant impact on follicular unit survival or scaffold survival. In this manner, hair implantation may mimic hair turnover by replenishing hairs lost to activities of daily living. That we know of, this study is the first to demonstrate the implementation of scaffold assisted hair implants. The benefit of delayed hair implantation to replenish hair attrition showed no increased rate of inflammation or scaffold extrusion.
Overall, 6 implants were extruded fewer than 48 hours after implantation, likely from social animal grooming (ie, biting of sutures) and excluded from the study. However, we cannot exclude early technical failure as the 5 scaffolds extruded from the 12-week group were among the first implanted overall in the study. One additional scaffold extruded following implantation within the delayed-implantation group. Animals were housed in pairs owing to the social nature of rats. The high overall retention of implants accentuates the robust healing despite the persistent contamination and manipulation from social grooming. The extent of postsurgical manipulation by human patients may be better controlled than the social grooming of rats and may improve outcomes. Finally, the location of implantation in the rat dorsum, which is extremely mobile, also places the implants at increased risk of explantation. As the scalp exhibits limited mobility, hair-bearing scaffold implantation would be expected to have improved retention relative to the mobile rat dorsum.
Overall, ePTFE scaffolds extruded more often (n = 7; 6 fully extruded, 1 partially extruded) compared with PE scaffolds (n = 2; 1 fully extruded, 1 partially extruded). However, Kaplan-Meier log-rank analysis did not show a significant difference in overall scaffold survival. Multiple studies have suggested that the porous character of PHDPE promotes a greater degree of fibrovascular integration and decreased infection and extrusion, which was suggested by this study. 34, 35 This increased fibrovascular integration was noted to be associated with increased acute and chronic inflammation in contrast to prior studies. 35 Scaffolds that were completely extruded and absent were excluded from histological analysis, as well as follicular unit and scaffold survival analysis. As a result, the histological results presented are likely biased toward less inflammation and infection because extruded scaffolds were likely associated with greater inflammation and infection. Additionally, the follicular unit survival analysis may overestimate follicular unit survival, which would likely be less in infected scaffolds.
Limitations
It has been well studied and documented that alloplastic materials may serve as long-term soft tissue implants. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] The limitation of this concept in the setting of an artificial hair transplant is that the hairs extruding from the implanted scaffold remain through the skin and remain a potential nidus for infection. 35 In this study, scaffolds with hair did not show any clinical purulence or infection. Notably, scaffolds with hair were noted to have greater degrees of acute and chronic inflammation at 24 weeks; however, scaffolds with hair did not have any significant difference in survival compared with scaffolds without hair. Future studies may evaluate the association between these levels of inflammation with scaffold and hair survival at longer time points.
With the results of this study, we demonstrate the feasibility of scaffold assisted artificial hair implantation. In the future, alterations may be made to the scaffold design, including alternative mechanical and chemical binding of the artificial hair to the scaffold to increase follicular unit retention. Other biocompatible materials may also be considered to minimize inflammation and infection. Additionally, the scalable implantation of artificial hairs within biocompatible scaffolds must be evaluated. Future scaffold designs may be hybridized to include a porous exterior but a nonporous interior that may provide additional immunologic protection of the artificial hair and greater tensile strength to anchor hairs. Production of the scaffolds themselves may be mechanized by 3-dimensional printing or produced through molds. Scaffold extrusion may be minimized with multilayer soft tissue closure. In addition, the scaffold itself may be anchored to underlying soft tissue, periosteum, or bone. Finally, the art of hair implantation must take into account the natural angle of hair as it exits the follicles. Future implants may be designed with directionality to mimic the aesthetic of natural hair.
Conclusions
That we know of, this study is the first to demonstrate the implementation of scaffold assisted artificial hair implantation, and PHDPE and ePTFE artificial hair-bearing scaffolds were well tolerated in a rat model. In addition, delayed hair implantation to replenish hair attrition showed no increased rate of inflammation or scaffold extrusion.
